衡量成功的NASA生命科学技术转移的经济回报。

IF 4.6 2区 管理学 Q1 MANAGEMENT Journal of Technology Transfer Pub Date : 2002-12-01 DOI:10.1023/a:1020207506064
Henry R Hertzfeld
{"title":"衡量成功的NASA生命科学技术转移的经济回报。","authors":"Henry R Hertzfeld","doi":"10.1023/a:1020207506064","DOIUrl":null,"url":null,"abstract":"<p><p>Since 1958 NASA has invested approximately $3.7 billion in life sciences R&D in the support of the successful human space flight program. There are numerous studies documenting the spin-off technologies that can be traced to NASA research and development activities. Most of these studies describe the technologies and their uses; however only a few measure the economic impact of the spin-offs and most of these are benefit/cost studies that tend to overstate benefits or underestimate costs. This study takes a different approach, measuring only economic impacts to the companies that developed successful spin-off products from NASA life sciences investments. A personal interview was conducted with each company and the benefits are conservatively estimated as the value-added by the NASA technology to the company's output and the amount of additional private R&D stimulated by the NASA R&D. This pilot study of fifteen companies, using a very conservative measurement technique, found a large return to companies that have successfully commercialized NASA life sciences spin-off products. Value-added benefits totaled over $1.5 billion and a NASA R&D total investment in these 15 technologies of $64 million was found to stimulate an additional $200 million in private R&D. The study also found that the largest benefits were from products developed and marketed by large companies, primarily because these companies had the financial and marketing resources to work on a scale unavailable to smaller companies. Many of the small companies reported very profitable product-lines as well as documented evidence of benefits extending to the commercial users of their products. However, the smaller companies often lacked either the ability or the desire to expand into much larger scale production. NASA and other government technology transfer programs may be overlooking an opportunity to enlarge the economic benefits from their spin-off technologies. When a federal R&D grant or contract ends, the formal relationship between the agency and the company also usually ends. However, the companies continue to use the prior connection to NASA for advertising and for developing new business partners. One recommendation of this study is for NASA to be more proactive with \"alumni\" companies and to help open additional financial and marketing doors for these companies.</p>","PeriodicalId":48228,"journal":{"name":"Journal of Technology Transfer","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2002-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1023/a:1020207506064","citationCount":"32","resultStr":"{\"title\":\"Measuring the economic returns from successful NASA life sciences technology transfers.\",\"authors\":\"Henry R Hertzfeld\",\"doi\":\"10.1023/a:1020207506064\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Since 1958 NASA has invested approximately $3.7 billion in life sciences R&D in the support of the successful human space flight program. There are numerous studies documenting the spin-off technologies that can be traced to NASA research and development activities. Most of these studies describe the technologies and their uses; however only a few measure the economic impact of the spin-offs and most of these are benefit/cost studies that tend to overstate benefits or underestimate costs. This study takes a different approach, measuring only economic impacts to the companies that developed successful spin-off products from NASA life sciences investments. A personal interview was conducted with each company and the benefits are conservatively estimated as the value-added by the NASA technology to the company's output and the amount of additional private R&D stimulated by the NASA R&D. This pilot study of fifteen companies, using a very conservative measurement technique, found a large return to companies that have successfully commercialized NASA life sciences spin-off products. Value-added benefits totaled over $1.5 billion and a NASA R&D total investment in these 15 technologies of $64 million was found to stimulate an additional $200 million in private R&D. The study also found that the largest benefits were from products developed and marketed by large companies, primarily because these companies had the financial and marketing resources to work on a scale unavailable to smaller companies. Many of the small companies reported very profitable product-lines as well as documented evidence of benefits extending to the commercial users of their products. However, the smaller companies often lacked either the ability or the desire to expand into much larger scale production. NASA and other government technology transfer programs may be overlooking an opportunity to enlarge the economic benefits from their spin-off technologies. When a federal R&D grant or contract ends, the formal relationship between the agency and the company also usually ends. However, the companies continue to use the prior connection to NASA for advertising and for developing new business partners. One recommendation of this study is for NASA to be more proactive with \\\"alumni\\\" companies and to help open additional financial and marketing doors for these companies.</p>\",\"PeriodicalId\":48228,\"journal\":{\"name\":\"Journal of Technology Transfer\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2002-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1023/a:1020207506064\",\"citationCount\":\"32\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Technology Transfer\",\"FirstCategoryId\":\"91\",\"ListUrlMain\":\"https://doi.org/10.1023/a:1020207506064\",\"RegionNum\":2,\"RegionCategory\":\"管理学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MANAGEMENT\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Technology Transfer","FirstCategoryId":"91","ListUrlMain":"https://doi.org/10.1023/a:1020207506064","RegionNum":2,"RegionCategory":"管理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MANAGEMENT","Score":null,"Total":0}
引用次数: 32

摘要

自1958年以来,美国宇航局已经在生命科学研发方面投资了大约37亿美元,以支持成功的人类太空飞行计划。有许多研究记录了可以追溯到NASA研究和开发活动的附带技术。这些研究大多描述了这些技术及其用途;然而,只有少数研究衡量附带利益的经济影响,其中大多数是效益/成本研究,往往夸大效益或低估成本。这项研究采用了一种不同的方法,只衡量了从NASA生命科学投资中开发成功衍生产品的公司的经济影响。对每家公司进行了个人访谈,保守估计收益为NASA技术对公司产出的附加值和NASA研发刺激的额外私人研发量。这项对15家公司的试点研究,使用了一种非常保守的测量技术,发现那些成功地将NASA生命科学衍生产品商业化的公司获得了巨大的回报。附加值收益总计超过15亿美元,美国宇航局在这15项技术上的研发总投资为6400万美元,从而刺激了另外2亿美元的私人研发。该研究还发现,最大的好处来自大公司开发和销售的产品,主要是因为这些公司拥有小公司无法获得的资金和营销资源。许多小公司报告了非常有利可图的产品线,并有文件证明其产品的商业用户受益。然而,较小的公司往往缺乏能力或愿望扩大到更大规模的生产。美国国家航空航天局和其他政府技术转让项目可能忽视了扩大其附带技术的经济效益的机会。当联邦研发拨款或合同结束时,该机构与公司之间的正式关系通常也会结束。然而,这些公司继续利用先前与NASA的联系进行广告宣传和开发新的商业伙伴。这项研究的一个建议是NASA更积极地与“校友”公司合作,并帮助这些公司打开额外的财务和营销大门。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Measuring the economic returns from successful NASA life sciences technology transfers.

Since 1958 NASA has invested approximately $3.7 billion in life sciences R&D in the support of the successful human space flight program. There are numerous studies documenting the spin-off technologies that can be traced to NASA research and development activities. Most of these studies describe the technologies and their uses; however only a few measure the economic impact of the spin-offs and most of these are benefit/cost studies that tend to overstate benefits or underestimate costs. This study takes a different approach, measuring only economic impacts to the companies that developed successful spin-off products from NASA life sciences investments. A personal interview was conducted with each company and the benefits are conservatively estimated as the value-added by the NASA technology to the company's output and the amount of additional private R&D stimulated by the NASA R&D. This pilot study of fifteen companies, using a very conservative measurement technique, found a large return to companies that have successfully commercialized NASA life sciences spin-off products. Value-added benefits totaled over $1.5 billion and a NASA R&D total investment in these 15 technologies of $64 million was found to stimulate an additional $200 million in private R&D. The study also found that the largest benefits were from products developed and marketed by large companies, primarily because these companies had the financial and marketing resources to work on a scale unavailable to smaller companies. Many of the small companies reported very profitable product-lines as well as documented evidence of benefits extending to the commercial users of their products. However, the smaller companies often lacked either the ability or the desire to expand into much larger scale production. NASA and other government technology transfer programs may be overlooking an opportunity to enlarge the economic benefits from their spin-off technologies. When a federal R&D grant or contract ends, the formal relationship between the agency and the company also usually ends. However, the companies continue to use the prior connection to NASA for advertising and for developing new business partners. One recommendation of this study is for NASA to be more proactive with "alumni" companies and to help open additional financial and marketing doors for these companies.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
10.20
自引率
12.50%
发文量
66
期刊介绍: The Journal of Technology Transfer provides an international forum for research on the economic, managerial and policy implication of technology transfer, entrepreneurship, and innovation. The Journal is especially interested in articles that focus on the relationship between the external environment and organizations (governments, public agencies, firms, universities) and their innovation process. The Journal welcomes alternative modes of presentation ranging from broad empirical analyses, to theoretical models, to case studies based on theoretical foundations.  Officially cited as: J Technol Transf
期刊最新文献
An empirical investigation into UK university–industry collaboration: the development of an impact framework Supply chain constraints and research spending: an international investigation A micro-level study of research impact and motivational diversity Public biofoundries as innovation intermediaries: the integration of translation, sustainability, and responsibility Analysis of factors influencing attitude and intention to use electric vehicles for a sustainable future
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1